IRIS
MORETTA, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 70.446
AS - Asia 5.963
NA - Nord America 3.004
SA - Sud America 465
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 79.972
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 69.354
US - Stati Uniti d'America 2.795
SG - Singapore 2.730
CN - Cina 1.554
VN - Vietnam 1.013
FR - Francia 552
BR - Brasile 295
HK - Hong Kong 197
FI - Finlandia 151
BD - Bangladesh 105
DE - Germania 105
CA - Canada 85
JP - Giappone 83
AR - Argentina 71
MX - Messico 71
CH - Svizzera 67
GB - Regno Unito 66
IN - India 42
ID - Indonesia 37
IQ - Iraq 32
NL - Olanda 29
RU - Federazione Russa 27
PH - Filippine 26
EC - Ecuador 25
ZA - Sudafrica 22
CO - Colombia 19
PK - Pakistan 18
TH - Thailandia 15
TW - Taiwan 14
VE - Venezuela 14
UZ - Uzbekistan 12
CL - Cile 11
IE - Irlanda 11
JM - Giamaica 11
PY - Paraguay 11
CR - Costa Rica 10
ES - Italia 10
JO - Giordania 9
KE - Kenya 9
MA - Marocco 9
PE - Perù 9
PL - Polonia 9
SE - Svezia 9
SA - Arabia Saudita 8
UA - Ucraina 8
DZ - Algeria 7
MY - Malesia 7
EG - Egitto 6
KR - Corea 6
RO - Romania 6
TN - Tunisia 6
AZ - Azerbaigian 5
GA - Gabon 5
MM - Myanmar 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CI - Costa d'Avorio 4
HN - Honduras 4
KZ - Kazakistan 4
LB - Libano 4
NI - Nicaragua 4
NO - Norvegia 4
OM - Oman 4
PR - Porto Rico 4
PS - Palestinian Territory 4
TR - Turchia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AO - Angola 3
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CG - Congo 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GT - Guatemala 3
GY - Guiana 3
IR - Iran 3
LT - Lituania 3
NP - Nepal 3
SI - Slovenia 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
GF - Guiana Francese 2
MD - Moldavia 2
ML - Mali 2
NG - Nigeria 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
Totale 79.946
Salva come PNG Salva come JPEG
Città #
Genova 46.502
Genoa 13.057
Rapallo 5.525
Vado Ligure 3.870
Singapore 1.233
San Jose 1.142
Lauterbourg 524
Ho Chi Minh City 299
Ashburn 257
Hanoi 233
New York 224
Beijing 210
Hong Kong 186
Helsinki 151
Bordighera 120
Santa Clara 99
Frankfurt am Main 92
Council Bluffs 85
Tokyo 79
Zurich 67
Haiphong 50
Milan 47
Los Angeles 46
Tianjin 44
Mexico City 42
Da Nang 34
Shanghai 27
Montreal 24
São Paulo 24
Dallas 23
Atlanta 21
Chicago 21
Orem 21
Phoenix 21
Biên Hòa 20
Des Moines 19
Amsterdam 18
Buffalo 18
City of London 17
Rome 17
Baghdad 15
Duarte 15
Hải Dương 15
San Francisco 14
Toronto 14
Valenza 14
Denver 13
Ninh Bình 13
Bangkok 11
Boardman 11
Dublin 11
London 11
Naples 11
Tashkent 11
Cardiff 10
Jakarta 10
Amman 9
Can Tho 9
Ha Long 9
Mumbai 9
Paris 9
San José 9
Thái Nguyên 9
Chennai 8
Guangzhou 8
Johannesburg 8
Lima 8
Nairobi 8
Poplar 8
Cape Town 7
Fortaleza 7
Guayaquil 7
Hangzhou 7
Rio de Janeiro 7
Stockholm 7
Thái Bình 7
Turin 7
Brooklyn 6
Buenos Aires 6
Charlotte 6
Hưng Yên 6
Kingston 6
Lahore 6
Manchester 6
Moscow 6
Nha Trang 6
Quảng Ngãi 6
Quận Ba 6
Santiago 6
Seattle 6
Secaucus 6
Baku 5
Boston 5
Brasília 5
Bắc Ninh 5
Caracas 5
Dhaka 5
Hamilton 5
Kyiv 5
Las Vegas 5
Totale 75.004
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stem cell-Natural Killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. 448
Identification of cytomegalovirus (CMV)-specific T lymphocytes displaying an effector-memory phenotype that kill CMV-infected target cells in an HLA-E-restricted fashion 255
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 254
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 247
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 237
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 234
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 230
Dendritic cell editing by natural killer cells. 225
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 223
Unique Eomes+ NK cell subsets are present in uterus and decidua during early pregnancy 219
Human NK cells at early stages of differentiation produce large amounts of CXCL8 and express CD161 molecule that that functions as an activating receptor 215
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function 214
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 213
2B4 functions as a co-receptor in human NK cell activation 212
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 212
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia 210
T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells. 207
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 205
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 203
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 203
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 202
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 201
A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. 198
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 197
A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. 195
Interactions Between Mesenchymal Stem Cells and Dendritic Cells. 195
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 193
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 193
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 193
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. 192
Effect of tumor cells and tumor microenvironment on NK-cell function. 191
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 189
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 188
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 188
T gamma delta cells and their subsets in blood and synovial tissue from rheumatoid arthritis patients. 187
IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors 187
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 187
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK cell function 186
MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2 186
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 186
Haploidentical Haematopoietic Stem Cell Transplantation: Role of NK Cells and Effect of Cytomegalovirus Infections 186
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? 185
A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). 185
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 185
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 185
Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. 185
Role of Nrf2, HO-1 and GSH in neuroblastoma cell resistance to bortezomib 184
HO-1 up-regulation: A key point in high-risk neuroblastoma resistance to bortezomib. 184
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 184
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 183
Human innate lymphoid cells 183
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 182
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 181
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 181
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 181
Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. 180
Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. 180
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 180
Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones. 179
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. 179
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. 178
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. 177
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 177
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance 177
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. 176
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. 176
Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors. 176
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin. 176
Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. 175
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells 175
Surface antigens specifically expressed by activated T cells in humans. 173
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 173
Human NK receptors: from the molecules to the therapy of high risk leukemias. 173
Characterization of human afferent lymph dendritic cells from seroma fluids. 173
Learning how to discriminate between friends and enemies,a lesson from Natural Killer cells 172
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition 172
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 171
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 171
Alloreactive natural killer cells in targeting high-risk leukaemias. 171
HO-1 induction in cancer progression: A matter of cell adaptation 171
KIR and KIR ligand polymorphism: a new area for clinical applications? 171
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 170
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 170
A novel pathway of human B cell activation initiated by CK226 surface antigen. 170
MSC and innate immune cell interactions: A lesson from human decidua 170
Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. 170
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 170
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 169
Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. 168
Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. 168
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 168
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 168
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 167
Development of human natural killer cells and other innate lymphoid cells. 167
Familial hemophagocytic lymphohistiocytosis: a model for understanding the human machinery of cellular cytotoxicity. 167
Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells 167
Popolazione di precursori linfoidi umani, metodo per la loro identificazione e relativi usi 167
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 167
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. 166
Stimulatory receptors in NK and T cells. 166
Totale 19.001
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.643
article - articoli 221.763
book - libri 338
conference - conferenze 8.227
curatela - curatele 0
other - altro 0
patent - brevetti 1.484
selected - selezionate 0
volume - volumi 2.831
Totale 469.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021347 0 0 0 0 0 0 0 0 0 0 0 347
2021/20227.215 208 533 780 816 378 316 413 1.714 240 661 278 878
2022/20236.609 703 374 94 656 1.098 1.296 6 538 1.187 45 533 79
2023/20243.025 148 457 88 402 296 514 130 172 217 68 172 361
2024/20258.945 146 757 367 557 1.455 817 855 1.294 369 434 783 1.111
2025/202614.909 1.711 401 882 1.377 1.989 1.775 2.721 704 941 1.482 632 294
Totale 80.555